Rockwell Medical (NASDAQ:RMTI) Upgraded at RODMAN&RENSHAW

RODMAN&RENSHAW upgraded shares of Rockwell Medical (NASDAQ:RMTI) to a strong-buy rating in a research note published on Thursday,Zacks.com reports.

Several other analysts have also commented on the company. HC Wainwright reaffirmed a “buy” rating and issued a $9.00 price target on shares of Rockwell Medical in a research note on Wednesday, September 11th. StockNews.com raised Rockwell Medical from a “hold” rating to a “buy” rating in a research note on Wednesday. Finally, Rodman & Renshaw initiated coverage on Rockwell Medical in a research note on Thursday. They issued a “buy” rating and a $5.00 price target on the stock.

Rockwell Medical Stock Down 5.4 %

RMTI opened at $2.36 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.60 and a current ratio of 2.41. Rockwell Medical has a 1 year low of $1.16 and a 1 year high of $5.15. The stock’s 50 day simple moving average is $3.68 and its 200-day simple moving average is $2.61.

Institutional Investors Weigh In On Rockwell Medical

Several large investors have recently modified their holdings of RMTI. Armistice Capital LLC boosted its position in Rockwell Medical by 22.5% during the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock valued at $5,670,000 after purchasing an additional 592,000 shares during the last quarter. Vanguard Group Inc. boosted its position in Rockwell Medical by 4.0% during the first quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock valued at $1,856,000 after purchasing an additional 43,302 shares during the last quarter. Jane Street Group LLC acquired a new position in Rockwell Medical during the third quarter valued at approximately $534,000. Walleye Capital LLC acquired a new stake in shares of Rockwell Medical in the third quarter valued at approximately $435,000. Finally, Renaissance Technologies LLC lifted its position in shares of Rockwell Medical by 877.1% in the second quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock valued at $181,000 after buying an additional 92,189 shares during the last quarter. 23.31% of the stock is currently owned by institutional investors.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.